Abstract:Ebselen (EBS) is an organo-selenium-containing compound that has anti-inflammatory, antitumor, and antibacterial properties. EBS is being explored as a possible treatment for reperfusion injury and stroke and is under clinical trials as a mimetic of lithium for the treatment of bipolar disorder [Motaet al. Synapse 2020, 74 (7), 1−6] and noise-induced hearing loss as a result of these actives [Martini et al. J. Psychiatr. Res. 2019, 109, 107−117. Slusarczyket al. Neural Regener. Res. 2019, 17 (7), 1255–1261. Thangamaniet al. PLoS One 2015, 10 (7), e0133877. Kil et al. Lancet 2017, 390 (10098), 969–979]. However, we wanted to characterize derivatives of EBS as neuroprotective, anti-neuroinflammatory, and antioxidant compounds. Recently, we have reported on a new thermal and photoinduced copper-mediated cross-coupling between potassium selenocyanate (KSeCN) and N-substituted ortho-halobenzamides to form ebselen derivatives with increased synthetic efficiency [Thanna et al. J. Org. Chem. 2017, 82 (7), 3844−3854]. Our synthesis allows for the varying of the remote benzene ring with various substituents or replacing that ring with heterocyclic rings such as pyridine, pyrrole, thiophene, etc. In this study, we synthesized seven new heterocyclic EBS derivatives to further diversify our EBS library. These 21 compounds were then evaluated for their neuroprotective properties, with four compounds showing an equal or better neuroprotective profile than EBS. Compounds 5, 9, 23, and 27 showed 73, 86, 80, 84% cell viability, respectively, at a 10 μM concentration. These studies were performed using human neuroblastoma SH-SY5Y cells in an oxygen and glucose deprivation (OGD) model of ischemia. At the same concentration, these compounds significantly inhibited lipopolysaccharide-induced nitric oxide and tumor necrosis factor alpha release from Human microglia clone 3 microglial cells. Compounds 9 and 27 showed significantly increased cell viability (84 and 80%, respectively) for SH-SY5Y cells exposed to microglia-activated media. These compounds showed only mild GPx-like reductive activity, with compounds 2, 7, 12, and 14 (115, 96, 95, and 82%, respectively) showing a higher percent rate of oxidation of NADPH in a coupled reaction assay compared to ebselen. This research highlights several derivatives of ebselen that show improved activity as neuroprotective agents over the parent compound.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschemneuro.0c00328?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschemneuro.0c00328</a>.Supporting information include 1H NMR spectra, 13C NMR spectra of compounds 15a–21a and 15–21, and further experimental details (<a class="ext-link" href="/doi/suppl/10.1021/acschemneuro.0c00328/suppl_file/cn0c00328_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity

Natural Compounds as Inhibitors of Human Neutrophil Elastase

Identification and characterization of aptameric inhibitors of human neutrophil elastase

Utilization of computational methods for the identification of new natural inhibitors of human neutrophil elastase in inflammation therapy

(+)-Borneol Inhibits the Generation of Reactive Oxygen Species and Neutrophil Extracellular Traps Induced by Phorbol-12-myristate-13-acetate

Terpenoids as Human Neutrophil Elastase (HNE) Inhibitors: a comprehensive review of Natural Anti‐inflammatory Isoprenoids

Identification of novel human neutrophil elastase inhibitors from dietary phytochemicals using in silico and in vitro studies

Exploration of novel human neutrophil elastase inhibitors from natural compounds: Virtual screening, in vitro, molecular dynamics simulation and in vivo study

Synthesis and evaluation of benzenesulfonic acid derivatives as human neutrophil elastase (hNE) inhibitors

Investigating Polypharmacology through Targeting Known Human Neutrophil Elastase Inhibitors to Proteinase 3

Structure-activity relationships of dihydropyrimidone inhibitors against native and auto-processed human neutrophil elastase

Potential Inhibition of Human Neutrophil Elastase Enzyme to Attenuate Emphysema; A Molecular Docking Study

Robust anti-inflammatory activity of genistein against neutrophil elastase: a microsecond molecular dynamics simulation study

Neuroprotective and Anti-neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration

Non-peptide-based Fluorogenic Small-Molecule Probe for Elastase.

Ebselen oxide attenuates mechlorethamine dermatotoxicity in the mouse ear vesicant model

Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma

Synthesis, cytotoxicity, antioxidant activity and molecular modeling of new NSAIDs-EBS derivatives

Sulodexide protects endothelial cells against 4-hydroxynonenal-induced oxidative stress and glutathione-dependent redox imbalance by modulation of sestrin2/nuclear factor erythroid 2-related factor 2 pathway

Fractionated whole body γ-irradiation aggravates arthritic severity via boosting NLRP3 and RANKL expression in adjuvant-induced arthritis model: the mitigative potential of ebselen